Dr. Chinmay Jani (IMAGE)
Caption
“As precision medicine continues to evolve, we need to think beyond identifying individual mutations and begin understanding the broader biologic context in which those mutations occur,” said Chinmay T. Jani, M.D., medical oncologist at Sylvester and lead author of the study. “Our findings suggest that age may be an important piece of that puzzle. By better understanding how tumors change across the lifespan, we can continue refining how we interpret biomarkers, develop new therapies and personalize treatment strategies for patients with lung cancer.”
Credit
Sylvester Comprehensive Cancer Center
Usage Restrictions
Use with attribution
License
Original content